Pola Orbis Holdings (Pola Orbis Holdings) Risk Assessment

View and export this data going back to 2014. Start your Free Trial

What is Pola Orbis Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Pola Orbis Holdings is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Pola Orbis Holdings's Risk Assessment

For the Household & Personal Products subindustry, Pola Orbis Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pola Orbis Holdings's Risk Assessment Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Pola Orbis Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Pola Orbis Holdings's Risk Assessment falls into.

Pola Orbis Holdings (OTCPK:PORBF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Pola Orbis Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of Pola Orbis Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Pola Orbis Holdings (Pola Orbis Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Pola Orbis Holdings Inc (OTCPK:PORBF) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

4927:Japan

Address

2-2-3 Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031

Website

http://www.po-holdings.co.jp

Pola Orbis Holdings Inc is a beauty and health company. The company has a multibrand and multichannel strategy, being engaged in mail-order sales (online and catalog) and retail-store sales. The business divisions comprise the beauty care business, the real estate business, and others. The beauty care business, generating more than 90% of sales, has two main brands--Pola and Orbis--which are sold internationally. The real estate business leases office buildings, while the others segment is engaged in development of pharmaceutical and dermatological products.